CYTEK BIOSCIENCES INC's ticker is and the CUSIP is 23285D109. A total of 53 filers reported holding CYTEK BIOSCIENCES INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $26,512 | -60.7% | 4,803 | -39.2% | 0.00% | – |
| Q2 2023 | $67,457 | +21.1% | 7,899 | +30.3% | 0.00% | – |
| Q1 2023 | $55,709 | +12.2% | 6,062 | +24.7% | 0.00% | – |
| Q4 2022 | $49,651 | -32.9% | 4,863 | -4.2% | 0.00% | – |
| Q3 2022 | $74,000 | +111.4% | 5,077 | +54.4% | 0.00% | – |
| Q2 2022 | $35,000 | -84.1% | 3,288 | -83.9% | 0.00% | – |
| Q1 2022 | $220,000 | -29.7% | 20,474 | +6.6% | 0.00% | – |
| Q4 2021 | $313,000 | – | 19,204 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 2,100,000 | $22,533,000 | 12.24% |
| Miura Global Management | 1,649,400 | $17,698,000 | 12.14% |
| RA Capital Management | 13,381,054 | $143,578,000 | 3.83% |
| HHLR ADVISORS, LTD. | 8,757,030 | $93,963,000 | 2.01% |
| PURA VIDA INVESTMENTS, LLC | 477,164 | $5,120,000 | 0.30% |
| RTW INVESTMENTS, LP | 916,838 | $9,838,000 | 0.25% |
| Glenview Capital Management | 500,000 | $5,365,000 | 0.13% |
| GSA CAPITAL PARTNERS LLP | 73,743 | $791,000 | 0.12% |
| Parkwood LLC | 42,292 | $454,000 | 0.08% |
| Point72 Asset Management, L.P. | 1,536,079 | $16,482,000 | 0.07% |